Peptide questions · IGF-1 LR3
How long does IGF-1 LR3 take to work?
Reviewed Evidence: EmergingPublished by PepVault
IGF-1 LR3’s onset is 1–7 days (user reports), its peak effect comes at unknown in people; the animal studies ran 7 to 14 days, and its typical duration is 3–6 weeks per community cycle, by the library’s timeline (backed by preliminary research).
The timeline’s basis: Animal and cell studies only, most of them from one Adelaide group in the 1990s. No human trial of IGF-1 LR3 has been published; the human anchor for the class is the approved IGF-1 drug's label.
IGF-1 LR3 week by week
The library places five of its research notes on IGF-1 LR3 on the days they cover, from day 1 to day 56 and on: 1 on clinical data, 2 on community reports and 2 on animal studies.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–14 (weeks 1–2) | Low blood sugar is the thing to know first | Clinical data |
| Days 1–21 (weeks 1–3) | What people notice in the first weeks | Community report |
| Days 14–42 (weeks 2–6) | What the animal studies actually showed | Animal study |
| Days 21–56 (weeks 3–8) | The 20–30 hour half-life is not a measurement | Animal study |
| From day 42 on | Past six weeks: nothing is mapped | Community report |

The IGF-1 LR3 timeline’s milestones
The library’s timeline for IGF-1 LR3 marks 7 points from week 1 to week 8, backed by preliminary research overall.
- Week 1: Commonly reported in the first days: fuller muscles and a stronger pump, hunger, and for some the shaky, light-headed feeling of a blood-sugar dip within an hour or two of a dose
- Week 2: Works by escaping the IGF-binding proteins and reaching the IGF-1 receptor directly; in rat muscle cells that made it 5 to 10 times more potent than IGF-1
- Week 3: Commonly reported: recovery between hard sessions feeling easier; no human study has measured anything here
- Week 4: In rats, two weeks of continuous infusion raised body weight and nitrogen retention, with the gut especially responsive; in pigs the same infusion lowered weight gain and feed intake
- Week 5: Commonly reported at higher doses: water retention and aching joints, the same pattern GH users describe
- Week 6: Community cycles commonly end between weeks 3 and 6 with an equal break, a guard against receptor downregulation; that has not been tested in people
- Week 8: Past six weeks there is no animal or human data on repeated courses, and the tumor-monitoring line on the approved IGF-1 drug's label is written for long-term use
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why IGF-1 LR3 takes that long
The library states no half-life with a number for IGF-1 LR3 (it says: “Not measured in people: no human pharmacokinetic study of IGF-1 LR3 has been published. In rats it cleared from plasma about ten times faster than IGF-1 (Bastian 1993), because escaping the binding proteins is both what makes it potent and what lets it clear. The 20–30 hour figure repeated across community guides traces to one unreferenced sentence in the methods of a mouse atherosclerosis paper and has never been measured.”), so this page can’t work out a build-up; the timing rests on the notes above.
IGF-1 LR3 against other growth hormone compounds
The library holds an onset-and-peak timeline for 8 growth hormone compounds, IGF-1 LR3 among them; none of the others shares its onset of 1–7 days (user reports).
| Compound | Onset | Peak effect |
|---|---|---|
| Ipamorelin | 1–2 weeks | 8–12 weeks |
| CJC-1295 with DAC | 1–3 weeks | 8–12 weeks |
| CJC-1295 no DAC | 1–2 weeks | 8–12 weeks |
| Sermorelin | 1–2 weeks | 3–6 months |
| MK-677 | 1–3 days | 8–12 weeks |
| IGF-1 LR3 | 1–7 days (user reports) | Unknown in people; the animal studies ran 7 to 14 days |
| PEG-MGF | Unknown; nothing systemic is reported | Unknown in people or animals |
| Follistatin-344 | Unknown in people | Unknown in people; the gene-therapy trials measured at 6 months and a year |
Questions people ask
How long does IGF-1 LR3 take to work?
IGF-1 LR3’s onset is 1–7 days (user reports), its peak effect comes at unknown in people; the animal studies ran 7 to 14 days, and its typical duration is 3–6 weeks per community cycle, by the library’s timeline (backed by preliminary research).
When does IGF-1 LR3 reach its peak effect?
By the library’s timeline, IGF-1 LR3’s peak effect comes at unknown in people; the animal studies ran 7 to 14 days, backed by preliminary research.
How long is IGF-1 LR3 usually run?
The library’s timeline gives IGF-1 LR3’s typical duration as 3–6 weeks per community cycle; its cycle note says: Community cycles commonly run 3 to 6 weeks with an equal or longer break, on the belief that the IGF-1 receptor downregulates; no study has tested that in people.
What does the library say about the first days on IGF-1 LR3?
Its first note on IGF-1 LR3, for days 1–14 (weeks 1–2), is “Low blood sugar is the thing to know first”, resting on clinical data.